Investigating endothelial activation and oxidative stress in relation to glycaemic control in a multiethnic population.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3523138)

Published in Exp Diabetes Res on December 06, 2012

Authors

E M Brady1, D R Webb, D H Morris, K Khunti, D S C Talbot, N Sattar, M J Davies

Author Affiliations

1: Department of Diabetes Research, University Hospitals of Leicester, NHS Trust, Leicester LE5 4PW, UK. emer.brady@uhl-tr.nhs.uk

Articles cited by this

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet (1991) 11.30

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47

The clinical implications of endothelial dysfunction. J Am Coll Cardiol (2003) 6.71

Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet (2001) 4.60

Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41

Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes (2003) 4.40

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA (2004) 3.69

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation (1999) 2.90

Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation (2002) 2.84

Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension (2004) 2.80

New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care (2003) 2.74

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol (2004) 2.27

Endothelial function and oxidative stress in cardiovascular diseases. Circ J (2009) 2.26

Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes (2001) 2.21

Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States. Am J Cardiol (2004) 2.18

Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes (1998) 2.11

Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia (2006) 2.02

Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes. Eur Heart J (2001) 1.87

Oxidative stress and insulin action: is there a relationship? Diabetologia (1996) 1.86

Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation (1999) 1.79

Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes (2010) 1.78

Mortality and morbidity from diabetes in South Asians and Europeans: 11-year follow-up of the Southall Diabetes Survey, London, UK. Diabet Med (1998) 1.72

Role of oxidative stress in pancreatic beta-cell dysfunction. Ann N Y Acad Sci (2004) 1.68

Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care (2007) 1.60

Atherosclerosis and oxidative stress. Histol Histopathol (2008) 1.55

Prevalence and correlates of diabetes in South asian indians in the United States: findings from the metabolic syndrome and atherosclerosis in South asians living in america study and the multi-ethnic study of atherosclerosis. Metab Syndr Relat Disord (2010) 1.50

The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis (2008) 1.49

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials (2010) 1.45

F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers (2005) 1.44

Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol (1997) 1.17

Flow-mediated vasodilation as a diagnostic modality for vascular failure. Hypertens Res (2008) 1.12

Glucolipotoxicity in Pancreatic β-Cells. Diabetes Metab J (2011) 1.07

Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis (2004) 1.06

Low-dose docosahexaenoic acid lowers diastolic blood pressure in middle-aged men and women. J Nutr (2007) 1.05

Premature cardiovascular events and mortality in south Asians with type 2 diabetes in the United Kingdom Asian Diabetes Study - effect of ethnicity on risk. Curr Med Res Opin (2010) 1.03

Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Clin Biochem (2007) 1.00

Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Diabetologia (2006) 0.98

Systematic review on the association between F2-isoprostanes and cardiovascular disease. Ann Clin Biochem (2012) 0.96

High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women. J Clin Lipidol (2008) 0.96

F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids (1999) 0.88

Validity of self-assessed waist circumference in a multi-ethnic UK population. Diabet Med (2012) 0.86

Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy. QJM (2008) 0.86

Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study. Asia Pac J Clin Nutr (2012) 0.85

Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly. Diabetologia (2008) 0.82

Adhesion molecules and C-reactive protein are associated to adverse events in angina pectoris. Scand Cardiovasc J (2010) 0.79

Articles by these authors

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55

Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ (2008) 6.23

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J (1985) 5.83

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82

The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med (2006) 5.51

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med (1984) 5.02

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet (1989) 4.96

Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia (2012) 4.82

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32

A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) (1993) 4.25

THE IMPORTANCE OF THE SPLEEN IN RESISTANCE TO INFECTION. Ann Surg (1919) 4.14

Comparison of treatment of renal calculi by open surgery, percutaneous nephrolithotomy, and extracorporeal shockwave lithotripsy. Br Med J (Clin Res Ed) (1986) 3.99

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81

Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol (1997) 3.64

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation (2001) 3.57

Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol (1980) 3.21

Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int (2007) 3.17

Biochemistry and pathology of radical-mediated protein oxidation. Biochem J (1997) 3.14

Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem (2000) 2.79

Dietary polyunsaturated fatty acids and composition of human aortic plaques. Lancet (1994) 2.69

Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A (1991) 2.53

The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia (2007) 2.51

Community study of the causes of "natural" sudden death. BMJ (1988) 2.44

Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J Anat (2002) 2.33

The floppy mitral valve. Study of incidence, pathology, and complications in surgical, necropsy, and forensic material. Br Heart J (1978) 2.28

Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet (2003) 2.25

Retrospective review of care and outcomes in young adults with type 1 diabetes. BMJ (2003) 2.22

Clinical effectiveness of elective single versus double embryo transfer: meta-analysis of individual patient data from randomised trials. BMJ (2010) 2.19

Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia (2013) 2.19

Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia (2011) 2.12

Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis (1991) 2.10

Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review. Diabet Med (2000) 2.10

The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med (2010) 2.09

Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia (2011) 2.06

Unexplained death in fit young people. BMJ (1992) 2.03

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis (2009) 2.03

Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ (2010) 2.00

Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia (2009) 1.99

Absolute rate constants for the reaction of hypochlorous acid with protein side chains and peptide bonds. Chem Res Toxicol (2001) 1.91

Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies, UK. Diabetologia (2006) 1.90

External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants? Diabet Med (2013) 1.90

Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab (2001) 1.89

Features of primary health care teams associated with successful quality improvement of diabetes care: a qualitative study. Fam Pract (2001) 1.84

Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. Br Heart J (1976) 1.83

Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer (2001) 1.80

Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. Diabetes Res Clin Pract (2009) 1.79

Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids (2003) 1.79

Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation (1986) 1.78

Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet (1991) 1.76

Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol (2001) 1.74

Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74

The demonstration of cardiac pathology using perfusion-fixation. Histopathology (1985) 1.72

Generation and propagation of radical reactions on proteins. Biochim Biophys Acta (2001) 1.70

What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technol Assess (2012) 1.70

Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol (1980) 1.70

Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study. Diabetologia (2008) 1.70

Psychological morbidity and illness appraisals of patients with cardiac and non-cardiac chest pain attending a rapid access chest pain clinic: a longitudinal cohort study. Heart (2007) 1.69

Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes. Diabetes Obes Metab (2008) 1.68

Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord (2001) 1.68

The steinstrasse: A legacy of extracorporeal lithotripsy? 1988. Eur Urol (2006) 1.67

Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci U S A (1976) 1.67

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart (2000) 1.66

Extracorporeal shock wave lithotripsy: the first 50 patients treated in Britain. Br Med J (Clin Res Ed) (1985) 1.66

Bed rest and postlumbar puncture headache. The effectiveness of 24 hours' recumbency in reducing the incidence of postlumbar puncture headache. Anaesthesia (1989) 1.64

Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation (2001) 1.64

Anatomical basis of cross sectional echocardiography. Br Heart J (1983) 1.63

The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? Diabet Med (2011) 1.61

Mechanisms of progression in native coronary artery disease: role of healed plaque disruption. Heart (1999) 1.59

Idiopathic giant cell myocarditis--a distinctive clinico-pathological entity. Br Heart J (1975) 1.59

Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabet Med (2013) 1.51

Post-mortem investigation and quantification of coronary artery disease. Histopathology (1985) 1.51

Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis (2000) 1.50

Factors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008. Diabet Med (2014) 1.49

Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J (1990) 1.49

Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes. Lancet (1999) 1.48

Caries experience among children in fluoridated Townsville and unfluoridated Brisbane. Aust N Z J Public Health (1996) 1.48

The current status of myocardial disarray in hypertrophic cardiomyopathy. Br Heart J (1984) 1.47

The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial. Int J Clin Pract (2011) 1.47

Purification and characterization of a monoclonal T-cell suppressor factor specific for poly(LGlu60LAla30LTyr10). Proc Natl Acad Sci U S A (1982) 1.46

Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J (1998) 1.45

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials (2010) 1.45

Associations between exposure to fluoridated drinking water and dental caries experience among children in two Australian states. J Public Health Dent (1995) 1.45

Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction. Diabet Med (2007) 1.45

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency. Diabetes Obes Metab (2008) 1.44

Apoptotic versus autophagic cell death in heart failure. Cardiovasc Res (2001) 1.44

Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond) (2000) 1.44

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study. Int J Clin Pract (2010) 1.43

Reactive species and their accumulation on radical-damaged proteins. Trends Biochem Sci (1993) 1.42

Haematological effects of reinfused mediastinal blood after cardiac surgery. Med J Aust (1991) 1.42

The relation of coronary thrombosis to ischaemic myocardial necrosis. J Pathol (1979) 1.42

Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception. Diabet Med (2013) 1.41